Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00492206
Status:
COMPLETED
Last Update Posted:
2017-02-01
First Post:
2007-06-26
Brief Title:
Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC
Sponsor:
University of Pittsburgh
Organization:
University of Pittsburgh
Organization Data
Organization:
University of Pittsburgh
Class:
OTHER
Study ID:
05-106
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Pittsburgh
Lead Sponsor Class:
OTHER
Responsible Party:
Ahmad Tarhini
Responsible Party Title:
Associate Professor of Medicine and Translational Science
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Pittsburgh
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bristol-Myers Squibb | INDUSTRY |